UK clinical service evaluation of management of diabetes mellitus in patients with intestinal failure on Home Parenteral Nutrition (HPN)
Loading...
Contact
Check for full-text access
Issue Date
Type
Conference Proceedings
Language
Keywords
Alternative Title
Abstract
Aims To identify: 1 Prevalence of Type-1 and Type-2 Diabetes Mellitus (DM) in patients on HPN and development of T3DM 2 How the management of pre-existing diabetes changes with HPN 3 Who manages DM in patients on HPN and any significant challenges Methods UK HPN centres were invited to participate in this clinical service evaluation. The database, devised by the UHB IF team and diabetologists, was sent to participating centres to gather data for each HPN patient with diabetes mellitus with point-prevalence 31/12/2021. Data included IF and DM modes of management and subsequent complications. Results 21 centres (23 invited) from England, Wales and Northern Ireland reported 121 patients were diabetic from a total 2344 on HPN. The leading mechanism for IF was short bowel syndrome 59 (49%) followed by intestinal dysmotility 28 (23%). 43 (36%) patients were overweight and 19 (16%) obese. 18 (14%) of patients had Type-I DM. 38 (31%) had T2DM on Insulin, 12 (10%) had T2DM on oral hypoglycaemics, 9 (7%) had T2DM on Insulin and oral hypoglycaemics, 19 (16%) had T2DM that was diet controlled, 24 (20%) developed T3DM. Of those who were diabetic before starting PN, 28 (38%) didn't have changes in diabetic management, 18 (24%) required insulin therapy moved to overnight, 13 (17%) started insulin, 3 (4%) required insulin pump and 2(3%) oral hypoglycaemics. 8 (7%) of patients required reduction of calories, 5(4%) reduction in glucose days and 12 (10%) of patients had glucose bags avoided due to poor glycaemic control. PN was sole source of nutrition in 28 (23%) patients. 65 (54%) had diabetes managed by local diabetologist, 45 (37%) by GP and 6 (5%) by IF team. Glucose monitoring: 55(45%) of patients had home blood glucose monitoring, 43(36%) Hba1c and 14 (12%) Freestyle Libre. Conclusion * Point prevalence of diabetes on HPN was found to be 5%, with 20% a result of IF/HPN. * Clinicians found management of half of diabetic patients to be challenging, with 48% of patients requiring changes to management. * There was no standardisation of the management of diabetes with and further guidance is needed. References NA
Description
Citation
Publisher
License
Journal
Clinical Nutrition ESPEN
